Knoll Capital Management’s Lisata Therapeutics LSTA Stock Holding History

Knoll Capital Management’s Portfolio LSTA Stock Details LSTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-7,864	Closed	-$422K	–	15
2017 Q3	$422K	Hold	7,864	–	–	0.36%	14
2017 Q2	$549K	Hold	7,864	–	–	0.73%	12
2017 Q1	$593K	Buy	7,864 +4,159	+112%	+$288K	0.89%	14
2016 Q4	$157K	Sell	3,705 -14	-0.4%	-$804	0.28%	17
2016 Q3	$266K	Buy	3,719 +14	+0.4%	+$1.13K	0.47%	17
2016 Q2	$328K	Hold	3,705	–	–	0.11%	18
2016 Q1	$417K	Hold	3,705	–	–	0.17%	17
2015 Q4	$600K	Sell	3,705 -2,962	-44%	-$544K	0.22%	16
2015 Q3	$1.49M	Hold	6,667	–	–	0.63%	10
2015 Q2	$1.87M	Buy	+6,667	New	+$2.48M	0.6%	11

Other funds holding LSTA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

STA

Summit Trail Advisors New York $6.98B AUM 19.51% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Knoll Capital Management's LSTA Position: Q4 2017 in Review

Knoll Capital Management sold out of Lisata Therapeutics (LSTA) in Q4 2017, closing a stake of 7,864 shares — an estimated $422K sold.

Knoll Capital Management first reported a position in LSTA in Q2 2015 and held it in 10 quarters. The position peaked at $1.87M in Q2 2015. 24 funds tracked by Wall St. Rank hold LSTA as of Q4 2017.

Knoll Capital Management reported no remaining Lisata Therapeutics position as of Q4 2017 after selling out during the quarter.
Knoll Capital Management sold 7,864 Lisata Therapeutics shares in Q4 2017, an estimated $422K.
Knoll Capital Management first reported a position in Lisata Therapeutics in Q2 2015 and held it in 10 quarters.
Knoll Capital Management's Lisata Therapeutics position peaked at $1.87M in Q2 2015.
24 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q4 2017.

Based on Knoll Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.